Item 5.02 (b) and (e). Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers
Ronald A. Rittenmeyer, who had served as the Executive Chairman of Tenet
Healthcare Corporation (the "Company") and as a member of the board of directors
of the Company (the "Board"), resigned due to personal health reasons effective
as of October 1, 2022. The Board appointed J. Robert Kerrey as Chairman of the
Board effective as of October 1, 2022, and reduced the number of authorized
directors on the Board to ten.
On October 1, 2022, the Company entered into a letter agreement with
Mr. Rittenmeyer pursuant to which the Company has agreed to treat
Mr. Rittenmeyer's resignation as a termination on account of disability pursuant
to the terms of his employment agreement. A copy of the letter agreement is
attached as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated
herein by reference.
Senator Kerrey first joined the Board in 2001, and served most recently as Lead
Director. Senator Kerrey has served as Managing Director at Allen & Company, an
investment firm, since 2014, and as Executive Chairman of the Minerva Institute
for Research and Scholarship since 2013. Prior to joining the Board, Senator
Kerrey served as a United States senator from the state of Nebraska. Senator
Kerrey holds a Bachelor of Science degree in pharmacy from the University of
Nebraska. Additional information regarding Senator Kerrey's business experience
is included in the Company's SEC filings and on its website.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No. Description
10.1 Letter Agreement between Tenet Healthcare Corporation and Ronald
Rittenmeyer, dated October 1, 2022
104 Cover Page Interactive Data File (embedded within the inline XBRL
document)
2
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
TENET HEALTHCARE CORPORATION 
